静脉全氟丙烷纳米液滴的声学激活成像可选择性生物激活风险区域
研究在大鼠和猪急性心肌缺血/再灌注模型中静脉注射全氟丙烷液滴,用诊断性经胸超声进行声学激活,发现激活区域与梗死/瘢痕区相关,24小时内激活与梗死区一氧化氮利用增加相关(P<.05),猪7天时声学激活范围与梗死面积相关(r=.74,P<.01)。
要点
- 静脉全氟丙烷液滴经诊断性超声激活后,声学激活区主要位于心肌梗死/瘢痕区。
- 大鼠缺血/再灌注24小时内声学激活与梗死区一氧化氮利用增加相关(P<.05)。
- 猪7天时声学激活空间范围与梗死面积相关(r=.74,P<.01)。
核心结论
- 静脉全氟丙烷液滴的声学激活可增强缺血/再灌注后发展中瘢痕区,并导致选择性组织一氧化氮利用。
研究设计与样本
- 研究论文;36只大鼠和20只猪在心肌缺血/再灌注后不同阶段(30分钟、1天、7天)静脉注射全氟丙烷液滴,采用诊断性经胸超声频率进行声学激活,并与组织学、髓过氧化物酶活性和组织亚硝酸盐活性相关。
关键影像表现/征象
- 大鼠梗死区内声学激活程度与胶原含量、中性粒细胞浸润或梗死时间无关联。
- 猪的声学激活空间范围仅在7天处死前进行时与梗死面积相关(r=.74,P<.01)。
诊断标准与关键数值
- 大鼠缺血/再灌注24小时内声学激活与梗死区内一氧化氮利用增加相关(P<.05,与远隔区比较)。
- 猪7天时声学激活空间范围与梗死面积相关(r=.74,P<.01)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Acoustically activatable perfluoropropane droplets (PD) can be formulated from commercially available microbubble preparations. Diagnostic transthoracic ultrasound frequencies have resulted in acoustic activation (AA) predominately within myocardial infarct zones (IZ).
OBJECTIVE: We hypothesized that the AA area following acute coronary ischemia/reperfusion (I/R) would selectively enhance the developing scar zone, and target bioeffects specifically to this region.
METHODS: We administered intravenous PD in 36 rats and 20 pigs at various stages of myocardial scar formation (30 minutes, 1 day, and 7 days post I/R) to determine what effect infarct age had on the AA within the IZ. This was correlated with histology, myeloperoxidase activity, and tissue nitrite activity.
RESULTS: The degree of AA within the IZ in rats was not associated with collagen content, neutrophil infiltration, or infarct age. AA within 24 hours of I/R was associated with increased nitric oxide utilization selectively within the IZ (P < .05 compared with remote zone). The spatial extent of AA in pigs correlated with infarct size only when performed before sacrifice at 7 days (r = .74, P < .01).
CONCLUSIONS: Acoustic activation of intravenous PD enhances the developing scar zone following I/R, and results in selective tissue nitric oxide utilization.
引用
- Li S, Chen C, Lof J, et al. Acoustic Activation Imaging With Intravenous Perfluoropropane Nanodroplets Results in Selective Bioactivation of the Risk Area. J Ultrasound Med. 2024. PMID: 38440926. doi:10.1002/jum.16435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。